cough syrup deaths
Investigation Reveals Safety Lapses and Regulatory Failures in Fatal Cough Syrup Contamination Case
Nov 21, 2025 04:14 pm CST
An exclusive investigation into the deaths of 24 children from contaminated cough syrup has uncovered serious safety breaches in India's pharmaceutical supply chain. The report details how improper handling of propylene glycol solvent, unauthorized repackaging by unlicensed distributors, and inadequate regulatory oversight may have allowed toxic diethylene glycol to contaminate Coldrif cough syrup, raising new concerns about quality control in India's $50 billion pharmaceutical industry.
Deadly Commission: Doctor Received Rs 2.5 For Each Bottle of Toxic Cough Syrup That Killed 23 Children
Oct 14, 2025 07:33 pm CST
An investigation into the Madhya Pradesh cough syrup tragedy reveals a disturbing pharmaceutical kickback scheme where Dr. Praveen Soni received a 10% commission for prescribing Coldrif syrup that contained toxic diethylene glycol, resulting in 23 children's deaths. The case exposes broader concerns about pharmaceutical corruption and medical ethics in India's healthcare system.
ED Raids Premises of Pharmaceutical Firm Linked to Fatal Cough Syrup: 20 Children Dead from Contaminated Medication
Oct 13, 2025 12:14 pm CST
The Enforcement Directorate has raided multiple premises of Sresan Pharmaceuticals, manufacturer of 'Coldrif' cough syrup that contained toxic diethylene glycol and caused at least 20 children's deaths. The investigation revealed over 350 violations at the company's facility, prompting state bans and WHO concerns about India's regulatory gaps in drug safety screening.
CAG Report Reveals Madhya Pradesh's Procurement of Banned Drugs Amid Fatal Cough Syrup Incident
Oct 10, 2025 11:21 pm CST
A recent CAG audit has revealed that Madhya Pradesh's public health corporation procured banned medications worth Rs 1.8 crore between 2017-2022, despite central prohibitions. This regulatory failure has gained heightened scrutiny following the deaths of 23 children from toxic cough syrup in Chhindwara, raising serious concerns about the state's pharmaceutical safety protocols and oversight mechanisms.
WHO Warns of Regulatory Gaps After Fatal Cough Syrup Contamination in India
Oct 09, 2025 01:10 pm CST
The World Health Organization has raised concerns about India's regulatory gaps in screening for toxic chemicals in medicines after contaminated cough syrups caused the deaths of 20 children in Madhya Pradesh and Rajasthan. WHO highlighted the potential international risk of such products being exported through unregulated channels, following the discovery of high levels of diethylene glycol in several cough syrup brands.
India's Drug Regulator Acknowledges Pharmaceutical Manufacturing Lapses Following Fatal Cough Syrup Incidents
Oct 09, 2025 12:51 am CST
India's top drug regulator has admitted serious deficiencies in pharmaceutical manufacturing practices after children died from suspected contaminated cough syrups. CDSCO investigations revealed manufacturers failing to test raw materials and finished products as required by law, leading to stricter enforcement measures nationwide. The scandal has damaged India's reputation as a global pharmaceutical supplier, with multiple states implementing emergency restrictions on cough medication distribution.
India's Drug Regulator Issues Critical Advisory Following Fatal Cough Syrup Contamination Cases
Oct 09, 2025 12:51 am CST
India's drug regulator has issued an urgent advisory highlighting serious lapses in pharmaceutical manufacturing practices after multiple child deaths linked to contaminated cough syrups. Inspections revealed manufacturers failing to test raw materials and finished products as required by law, prompting increased regulatory scrutiny across states and renewed concerns about India's pharmaceutical quality control systems.
FAIMA Urges Health Ministry to Form Central Committee to Investigate Fatal Contaminated Cough Syrup Cases
Oct 08, 2025 09:07 pm CST
The Federation of All India Medical Association (FAIMA) has called for a central investigation committee to examine the deaths of over 20 children in Madhya Pradesh and Rajasthan linked to contaminated Coldrif cough syrup. The medical body emphasized the need for nationwide testing of pediatric medications, improved regulatory coordination, and protection of physicians from premature blame while ensuring pharmaceutical safety standards are enforced.
Medical Body Condemns Scapegoating of Doctor in Madhya Pradesh Cough Syrup Deaths Tragedy
Oct 08, 2025 07:36 pm CST
The Federation of All India Medical Association criticizes authorities for making a doctor the scapegoat in the Madhya Pradesh cough syrup tragedy that claimed 16 children's lives. FAIMA Chief Patron Dr. Rohan Krishnan argues that responsibility lies with regulatory bodies that approved the medication containing ingredients banned for young children, highlighting systemic failures in pharmaceutical safety oversight and government awareness campaigns.
Deadly Oversight: Coldrif Cough Syrup Contains Banned Ingredients Linked to Multiple Child Deaths in India
Oct 08, 2025 02:13 pm CST
An investigation reveals that Coldrif cough syrup, linked to 19 children's deaths in Madhya Pradesh, contains ingredients banned for children under four years and dangerous levels of diethylene glycol. Despite a 2023 government directive requiring warning labels and WHO-GMP certification requirements following global child fatalities from contaminated medications, the manufacturer Sresan Pharmaceuticals continued production with 480 times the permitted toxic chemical level without proper certification.